The FAK inhibitor BI 853520 exerts anti-tumor effects in breast cancer.

Tiede, Stefanie; Meyer-Schaller, Nathalie; Kalathur, Ravi Kiran Reddy; Ivanek, Robert; Fagiani, Ernesta; Schmassmann, Philip; Stillhard, Patrick; Häfliger, Simon; Kraut, Norbert; Schweifer, Norbert; Waizenegger, Irene C; Bill, Ruben; Christofori, Gerhard.

Afiliação

Tiede S; Department of Biomedicine, University of Basel, 4058, Basel, Switzerland.
Meyer-Schaller N; Department of Biomedicine, University of Basel, 4058, Basel, Switzerland.
Kalathur RKR; Department of Biomedicine, University of Basel, 4058, Basel, Switzerland.
Ivanek R; Swiss Institute of Bioinformatics, 4053, Basel, Switzerland.
Fagiani E; Department of Biomedicine, University of Basel, 4058, Basel, Switzerland.
Schmassmann P; Swiss Institute of Bioinformatics, 4053, Basel, Switzerland.
Stillhard P; Department of Biomedicine, University of Basel, 4058, Basel, Switzerland.
Häfliger S; Department of Biomedicine, University of Basel, 4058, Basel, Switzerland.
Kraut N; Department of Biomedicine, University of Basel, 4058, Basel, Switzerland.
Schweifer N; Department of Biomedicine, University of Basel, 4058, Basel, Switzerland.
Waizenegger IC; Boehringer Ingelheim RCV GmbH & Co KG, 1121, Vienna, Austria.
Bill R; Boehringer Ingelheim RCV GmbH & Co KG, 1121, Vienna, Austria.
Christofori G; Boehringer Ingelheim RCV GmbH & Co KG, 1121, Vienna, Austria.

Oncogenesis ; 7(9): 73, 2018 09 20.

Article em En | MEDLINE | ID: mdl-30237500

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article